Sun, Apr 5, 2020
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index Gains 0.71% in November (+9.84% YTD)

Thursday, December 19, 2013
Opalesque Industry Update - Hedge funds gained 0.71% in November, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 9.84% year to date.

“A rate cut in Europe, far-reaching reforms announced in China, and generally positive economic data contributed to a third month of rising equity prices," says Sol Waksman, founder and president of BarclayHedge.

Sixteen of Barclay’s 18 hedge fund indices had gains in November. The Barclay Healthcare & Biotechnology Index jumped 3.05%, Distressed Securities gained 1.71%, Global Macro added 1.68%, Equity Long Bias was up 1.55%, European Equities gained 1.37%, and Pacific Rim Equities were up 1.24%.

“In spite of a dismal launch that raised concerns about Obamacare’s longer term success, healthcare was the top performing sector in November as well as year to date," says Waksman.

The Healthcare & Biotechnology Index has gained 25.66% in 2013, Pacific Rim Equities are up 20.63%, Equity Long Bias Index has returned 19.23%, Distressed Securities have gained 15.89%, and Equity Long/Short is up 12.10%.

On the losing side, the Equity Short Bias Index was down 2.01% in November, and Emerging Markets lost 0.53%.

The Equity Short Bias Index is now down 25.32% in 2013, surpassing last year’s record loss of 24.12%. All other hedge fund strategies tracked by BarclayHedge have gains year to date.

The Barclay Fund of Funds Index gained 1.01% in November, and is up 7.22% after 11 months in 2013.


Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing: Ray Dalio's Bridgewater scales down European short bets after $3.2bn windfall, Here's what top hedge funds are buying in the coronavirus stock market crash[more]

    Ray Dalio's Bridgewater scales down European short bets after $3.2bn windfall From Financial News: Bridgewater Associates, the world's biggest hedge fund, has retreated from shorting European stocks after making an estimated €2.9bn ($3.2bn), as its founder and co-chairman Ray Dalio c

  2. Bill Ackman writes letter to shareholders on coronavirus[more]

    Pershing Square Holdings (PSH)'s Bill Ackman wrote a letter to investors outlining his insight on the coronavirus pandemic in the United States. He revealed that PSH completed the process of exiting the hedges on 23 March, netting a gross $2.1bn for PSH, after turning 'increasingly positive on equit

  3. New Launches: LGPS Central sets up investment grade bond fund, Leeds Equity Advisors aims to raise $1bn for PE fund, RLI Investors to launch European last-mile logistics fund, DBL Partners IV targets $450m[more]

    LGPS Central sets up investment grade bond fund From IPE: LGPS Central, the asset pooling vehicle for eight local government pension schemes (LGPS) based in England's Midlands, has launched a global investment grade corporate bond fund in order to meet its partner funds' needs. The po

  4. Investing: Marathon sees cheap assets amid dislocation in credit, Deerfield's health care buying spree, It's time to buy shares again, says BlackRock, Credit Suisse, Fed is buying credit ETFs but one hedge fund is shorting them[more]

    Marathon sees cheap assets amid dislocation in credit From Bloomberg: Distressed-investment specialist Marathon Asset Management is buying beaten-up debt amid the greatest dislocation in credit markets since 2008, according to Bruce Richards, co-founder and chief investment officer of the

  5. People: Carlyle picks 2 deputy heads for Japan buyout advisory team, Ex-Kleinwort Hambros adviser takes senior role at multi-family office boutique[more]

    Carlyle picks 2 deputy heads for Japan buyout advisory team From Takaomi Tomioka and Hiroyuki Otsuka were named deputy heads of the Japan buyout advisory team at Carlyle Group. The positions are new, confirmed a spokeswoman for the New York-based private markets investment g